CLASS II Drug recall · Reported 8 Oct 2014 · FDA Enforcement Report

Diclofenac Sodium and Misoprostol Delayed-Release Tablets recalled

Actavis Laboratories, FL is recalling Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 50 mg/0.2 mg, distributed nationwide in the US. The recall was initiated on 24 Apr 2014 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: 660513A, Exp. 10/31/2014
NDC0591-0397, 0591-0398
UPC0305910397609, 0305910398606, 305910397609
Quantity recalled6,041 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1617-2014
FDA event ID
69237
Recalling firm
Actavis Laboratories, FL, Davie, FL
Manufacturer
Actavis Pharma, Inc.
Classification
Class II
Status
Terminated
Recall initiated
24 Apr 2014
FDA classified
30 Sep 2014
Reported
8 Oct 2014
Type
Voluntary: Firm initiated
Customers notified by
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Reason category
Other Reasons
Drug class
Pain Medication

Timeline

24 Apr 2014Recall initiated by company
30 Sep 2014Classified by FDA+159 days
8 Oct 2014Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Tablet/Capsule Specifications: Recall due to complaints of split or broken tablets.

Product as listed by the FDA

Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 50 mg/0.2 mg, 60-count bottle, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA 92880, NDC 0591-0397-60, UPC 3 05910 39760 9.

Where it was distributed

Nationwide and Puerto Rico

Nationwide Puerto Rico

Questions about this recall

Is Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 50 mg/0.2 mg recalled?

Yes. Actavis Laboratories, FL recalled Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 50 mg/0.2 mg on 24 Apr 2014. The recall is Class II and its status is Terminated. Recall number D-1617-2014.

Why was it recalled?

Failed Tablet/Capsule Specifications: Recall due to complaints of split or broken tablets.

Which lots are affected?

Lot #: 660513A, Exp. 10/31/2014

Where was it sold?

Nationwide and Puerto Rico

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Actavis Laboratories, FL

All 7

Other Diclofenac Sodium recalls

All 6
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIDiclofenac Sodium and Misoprostol Delayed-Release Tablets recalledDiclofenac Sodium And MisoprostolActavis Laboratories, FLOtherNationwide
DrugCLASS IIDiclofenac Sodium and Misoprostol Delayed-Release Tablets recalledDiclofenac Sodium And MisoprostolActavis Laboratories, FLOtherNationwide
DrugCLASS IIDiclofenac Sodium and Misoprostol Delayed-Release Tablets recalledDiclofenac Sodium And MisoprostolWatson Laboratories, Inc.-(Actavis) - FloridaPotency & AssayNationwide
DrugCLASS IIDiclofenac Sodium and Misoprostol Delayed-Release Tablets recalledDiclofenac Sodium And MisoprostolActavisOtherNationwide
DrugCLASS IIDiclofenac Sodium and Misoprostol Delayed-Release Tablets recalledDiclofenac Sodium And MisoprostolWatson Laboratories, Inc.-(Actavis) - FloridaOtherNationwide